Clinical Advisory Board

The Clinical Advisory Board (CAB) focuses on infectious diseases, epidemiology, antibiotics and all medical aspects of the DebugIT project and solutions, providing first hand experience and knowledge needed for an optimal up-front design, as well as validation and further interpretation of results. At the regular CAB meetings, the experts provide feedback and critically comment on the priority areas, the ethical implications, usability aspects, and potential exploitation scenarios of the DebugIT outcomes.

Members of the Clinical Advisory Board external to the project:

Prof. Dr. Didier Pittet, [chairman] WHO World Alliance for Patient Safety

Didier Pittet is an internationally recognised opinion leader in the field of infection control and has published more than 100 original articles in peer-reviewed journals. In particular, he is an expert in the epidemiology and prevention of nosocomial infections, with a major interest in methods to improve compliance with hand hygiene practices among healthcare workers. He is involved in a number of national and international scientific collaborations.

Prof. Dr. Didier Guillemot, Institut Pasteur, Paris

Didier Guillemot is head of research of the unit ’Pharmacoepidemiology and Infectious Diseases’ at the Institut Pasteur in Paris. He is a well recognised expert on the study of the conditions of emergence and the diffusion of bacteria resistant to antibiotics.

Prof. Dr. Kendall Ho, University of British Columbia, Vancouver

Kendall Ho is a practicing emergency medicine specialist and director of eHealth strategy, University of British Columbia, Faculty of Medicine. He is an eHealth consultant to the Ministry of Health in British Columbia, Canada, and a member of the province’s eHealth Steering Committee.

Prof. Dr. Hans Rutberg, Linköping University Hospital

Hans Rutberg is chief physician at Linköping University Hospital with responsibility for patient safety. He is also a project leader of local and national projects for adverse event reporting and an expert consultant for the Board of Health and Welfare in Sweden.

Prof. Dr. Vilma Maresova, University Hospital Bulovka, Prague

Vilma Maresova is the Head of 1st Clinic for Infectious Diseases, University Hospital Bulovka, and Head of Dept. Infectious Diseases. Her interest in infectious diseases started in field of respiratory infections and neuroinfections. Since 1990 she has concentrated on the good antibiotic praxis, emphasising the collaboration with microbiologists and paediatricians, especially in community-acquired pneumonia, invasive pneumococcus diseases and other infectious diseases in children.

Prof. Dr. Javier Garau, European Society of Clinical Microbiology & Infectious Diseases

Javier Garau is President and Secretary General of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). He is also Associate Professor of Medicine and the Chair of the Department of Medicine at the University of Barcelona, Spain, as well as Chief of Service of Internal Medicine and Infectious Diseases at Hospital Mutua de Terrassa, Barcelona.

László Balkányi, MD, PhD, European Centre for Disease Prevention and Control (ECDC)

László Balkányi is knowledge manager at the Scientific Advice Unit of the European Centre for Disease Prevention and Control since 2006. His main activities are in the field of terminology services. Prior to joining ECDC, he was head expert of eHealth Programme Office of National Institute of Strategic Health Research (ESKI), as well as a senior lecturer at the University of Semmelweis. He is member of CEN TC 251, WG1,4, of Expert Panel, WHO EURO, HSD, past president, board member of the Hungarian Medical Informatics Association, of Medical Informatics Committee, Hungarian Academy of Sciences.

Members of the Clinical Advisory Board internal to the project:

Dr. Hĺkan Hanberger, Swedish Programme for Rational Use of Antimicrobial and Surveillance of Resistance (STRAMA)

Hĺkan Hanberger is chief physician at the Clinic of Infectious Diseases, Linköping University Hospital. He is also the Project leader of STRAMA (Swedish Programme for Rational Use of Antimicrobial and Surveillance of Resistance). His academic track record features 40 scientific publications in the field of infectious disease and antibiotic treatment.

Prof. Dr. Sten Walther, Swedish Intensive Care Registry

Sten Walther works at the Surgical Intensive Care Unit, Ullevĺl University Hospital, Faculty of Medicine, University of Oslo. He is chairmen of the Swedish SIR project (The Swedish Intensive Care Registry) with a close cooperation with Linköping University Hospital.

Dr. Hugo Sax, Les Hôpitaux Universitaires de Genčve

Hugo Sax is currently involved in research with a focus on epidemiology and prevention of nosocomial infections (especially Staphylococcus aureus resistant to methicillin), the impact and cost of infections in patients who are in critical condition, and use of technology information in forecasting and prevention of nosocomial infections at the University Hospital of Geneva.